Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?
Objective Borderline epithelial ovarian tumors have good prognosis without any adjuvant therapy. The advantage of aggressive surgical staging, especially retroperitoneal lymph node sampling is questionable in patients with borderline ovarian tumors. We designed this study to evaluate the necessity o...
Gespeichert in:
| Veröffentlicht in: | Archives of gynecology and obstetrics 2008-05, Vol.277 (5), p.411-414 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 414 |
|---|---|
| container_issue | 5 |
| container_start_page | 411 |
| container_title | Archives of gynecology and obstetrics |
| container_volume | 277 |
| creator | Pirimoglu, Zehra Meltem Afsin, Yasemin Guzelmeric, Kadir Yilmaz, Muberra Unal, Orhan Turan, Mehmet Cem |
| description | Objective
Borderline epithelial ovarian tumors have good prognosis without any adjuvant therapy. The advantage of aggressive surgical staging, especially retroperitoneal lymph node sampling is questionable in patients with borderline ovarian tumors. We designed this study to evaluate the necessity of retroperitoneal pelvic and para-aortic lymph node dissection in the treatment of borderline epithelial ovarian tumors.
Study design
From 1998 to 2007, 57 women who were diagnosed with borderline epithelial ovarian tumor in our hospital were prospectively accrued and evaluated; 27 of them (47.3%) had full surgical staging procedure including para-aortic and pelvic node dissection. Student’s
t
-test was used to compare follow-up times.
Results
Median follow-up time was 54.6 (12–96) months for all patients in the study. There was one recurrence of disease, which was in the complete staging group. Follow-up times of patients were not statistically different between lymph node evaluated and non-evaluated groups (
p
= 0.10). We did not find any metastasis in lymph nodes in 27 women who had complete surgical staging procedure.
Conclusion
Patients with borderline epithelial tumors who had full surgical staging procedure do not have survival advantage over those who had no lymph node evaluation and yet were patients with malignant ovarian tumors. |
| doi_str_mv | 10.1007/s00404-007-0478-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70449572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2261889403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-cab8a969f79a55ab63b8783a4bcce34aa4e6956c0b9693e4e03bbb1aae9dc5893</originalsourceid><addsrcrecordid>eNp1kE1rHSEUhqW0JDdpfkA3QShkN8lxdEZdhRCaDwhk0y66EvWe2xrm6o06gf77OtwLgUJXvuBz3nN4CPnC4JIByKsCIEB0LXYgpOr6D2TFBO87kIx9JCvQS4ZRHpOTUl4AWK_UeESOmdQCpBIr8vOx0FBpRI-l2PyH1kTXiWasOe0wh5oi2onim51mW0OKNETqUl5jnkJEirtQf-MUGpPebA420jpvUy7Xn8mnjZ0Knh3eU_Lj7tv324fu6fn-8fbmqfNcQu28dcrqUW-ktsNg3cidkopb4bxHLqwVOOph9OAaxFEgcOccsxb12g9K81Nyse_d5fQ6Y6lmG4rHabIR01yMBCH0IPsGfv0HfElzju020_cjU6o54Y1ie8rnVErGjdnlsG1mDAOzWDd762aJi3WzNJ8fmme3xfX7xEFzA_o9UNpX_IX5ffX_W_8CUXqOLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2261889403</pqid></control><display><type>article</type><title>Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Pirimoglu, Zehra Meltem ; Afsin, Yasemin ; Guzelmeric, Kadir ; Yilmaz, Muberra ; Unal, Orhan ; Turan, Mehmet Cem</creator><creatorcontrib>Pirimoglu, Zehra Meltem ; Afsin, Yasemin ; Guzelmeric, Kadir ; Yilmaz, Muberra ; Unal, Orhan ; Turan, Mehmet Cem</creatorcontrib><description>Objective
Borderline epithelial ovarian tumors have good prognosis without any adjuvant therapy. The advantage of aggressive surgical staging, especially retroperitoneal lymph node sampling is questionable in patients with borderline ovarian tumors. We designed this study to evaluate the necessity of retroperitoneal pelvic and para-aortic lymph node dissection in the treatment of borderline epithelial ovarian tumors.
Study design
From 1998 to 2007, 57 women who were diagnosed with borderline epithelial ovarian tumor in our hospital were prospectively accrued and evaluated; 27 of them (47.3%) had full surgical staging procedure including para-aortic and pelvic node dissection. Student’s
t
-test was used to compare follow-up times.
Results
Median follow-up time was 54.6 (12–96) months for all patients in the study. There was one recurrence of disease, which was in the complete staging group. Follow-up times of patients were not statistically different between lymph node evaluated and non-evaluated groups (
p
= 0.10). We did not find any metastasis in lymph nodes in 27 women who had complete surgical staging procedure.
Conclusion
Patients with borderline epithelial tumors who had full surgical staging procedure do not have survival advantage over those who had no lymph node evaluation and yet were patients with malignant ovarian tumors.</description><identifier>ISSN: 0932-0067</identifier><identifier>EISSN: 1432-0711</identifier><identifier>DOI: 10.1007/s00404-007-0478-2</identifier><identifier>PMID: 17940784</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adult ; Aged ; Biopsy ; Carcinoma - pathology ; Carcinoma - surgery ; Endocrinology ; Female ; Follow-Up Studies ; Gynecology ; Human Genetics ; Humans ; Lymph Node Excision ; Lymphatic system ; Medical prognosis ; Medicine ; Medicine & Public Health ; Middle Aged ; Needs Assessment ; Neoplasm Staging ; Obstetrics/Perinatology/Midwifery ; Original Article ; Ovarian cancer ; Ovarian Neoplasms - pathology ; Ovarian Neoplasms - surgery ; Prospective Studies ; Retroperitoneal Space ; Treatment Outcome ; Tumors</subject><ispartof>Archives of gynecology and obstetrics, 2008-05, Vol.277 (5), p.411-414</ispartof><rights>Springer-Verlag 2007</rights><rights>Archives of Gynecology and Obstetrics is a copyright of Springer, (2007). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c370t-cab8a969f79a55ab63b8783a4bcce34aa4e6956c0b9693e4e03bbb1aae9dc5893</citedby><cites>FETCH-LOGICAL-c370t-cab8a969f79a55ab63b8783a4bcce34aa4e6956c0b9693e4e03bbb1aae9dc5893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00404-007-0478-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00404-007-0478-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17940784$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pirimoglu, Zehra Meltem</creatorcontrib><creatorcontrib>Afsin, Yasemin</creatorcontrib><creatorcontrib>Guzelmeric, Kadir</creatorcontrib><creatorcontrib>Yilmaz, Muberra</creatorcontrib><creatorcontrib>Unal, Orhan</creatorcontrib><creatorcontrib>Turan, Mehmet Cem</creatorcontrib><title>Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?</title><title>Archives of gynecology and obstetrics</title><addtitle>Arch Gynecol Obstet</addtitle><addtitle>Arch Gynecol Obstet</addtitle><description>Objective
Borderline epithelial ovarian tumors have good prognosis without any adjuvant therapy. The advantage of aggressive surgical staging, especially retroperitoneal lymph node sampling is questionable in patients with borderline ovarian tumors. We designed this study to evaluate the necessity of retroperitoneal pelvic and para-aortic lymph node dissection in the treatment of borderline epithelial ovarian tumors.
Study design
From 1998 to 2007, 57 women who were diagnosed with borderline epithelial ovarian tumor in our hospital were prospectively accrued and evaluated; 27 of them (47.3%) had full surgical staging procedure including para-aortic and pelvic node dissection. Student’s
t
-test was used to compare follow-up times.
Results
Median follow-up time was 54.6 (12–96) months for all patients in the study. There was one recurrence of disease, which was in the complete staging group. Follow-up times of patients were not statistically different between lymph node evaluated and non-evaluated groups (
p
= 0.10). We did not find any metastasis in lymph nodes in 27 women who had complete surgical staging procedure.
Conclusion
Patients with borderline epithelial tumors who had full surgical staging procedure do not have survival advantage over those who had no lymph node evaluation and yet were patients with malignant ovarian tumors.</description><subject>Adult</subject><subject>Aged</subject><subject>Biopsy</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gynecology</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Lymphatic system</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Needs Assessment</subject><subject>Neoplasm Staging</subject><subject>Obstetrics/Perinatology/Midwifery</subject><subject>Original Article</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Prospective Studies</subject><subject>Retroperitoneal Space</subject><subject>Treatment Outcome</subject><subject>Tumors</subject><issn>0932-0067</issn><issn>1432-0711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kE1rHSEUhqW0JDdpfkA3QShkN8lxdEZdhRCaDwhk0y66EvWe2xrm6o06gf77OtwLgUJXvuBz3nN4CPnC4JIByKsCIEB0LXYgpOr6D2TFBO87kIx9JCvQS4ZRHpOTUl4AWK_UeESOmdQCpBIr8vOx0FBpRI-l2PyH1kTXiWasOe0wh5oi2onim51mW0OKNETqUl5jnkJEirtQf-MUGpPebA420jpvUy7Xn8mnjZ0Knh3eU_Lj7tv324fu6fn-8fbmqfNcQu28dcrqUW-ktsNg3cidkopb4bxHLqwVOOph9OAaxFEgcOccsxb12g9K81Nyse_d5fQ6Y6lmG4rHabIR01yMBCH0IPsGfv0HfElzju020_cjU6o54Y1ie8rnVErGjdnlsG1mDAOzWDd762aJi3WzNJ8fmme3xfX7xEFzA_o9UNpX_IX5ffX_W_8CUXqOLA</recordid><startdate>20080501</startdate><enddate>20080501</enddate><creator>Pirimoglu, Zehra Meltem</creator><creator>Afsin, Yasemin</creator><creator>Guzelmeric, Kadir</creator><creator>Yilmaz, Muberra</creator><creator>Unal, Orhan</creator><creator>Turan, Mehmet Cem</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20080501</creationdate><title>Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?</title><author>Pirimoglu, Zehra Meltem ; Afsin, Yasemin ; Guzelmeric, Kadir ; Yilmaz, Muberra ; Unal, Orhan ; Turan, Mehmet Cem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-cab8a969f79a55ab63b8783a4bcce34aa4e6956c0b9693e4e03bbb1aae9dc5893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biopsy</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gynecology</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Lymphatic system</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Needs Assessment</topic><topic>Neoplasm Staging</topic><topic>Obstetrics/Perinatology/Midwifery</topic><topic>Original Article</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Prospective Studies</topic><topic>Retroperitoneal Space</topic><topic>Treatment Outcome</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pirimoglu, Zehra Meltem</creatorcontrib><creatorcontrib>Afsin, Yasemin</creatorcontrib><creatorcontrib>Guzelmeric, Kadir</creatorcontrib><creatorcontrib>Yilmaz, Muberra</creatorcontrib><creatorcontrib>Unal, Orhan</creatorcontrib><creatorcontrib>Turan, Mehmet Cem</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pirimoglu, Zehra Meltem</au><au>Afsin, Yasemin</au><au>Guzelmeric, Kadir</au><au>Yilmaz, Muberra</au><au>Unal, Orhan</au><au>Turan, Mehmet Cem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?</atitle><jtitle>Archives of gynecology and obstetrics</jtitle><stitle>Arch Gynecol Obstet</stitle><addtitle>Arch Gynecol Obstet</addtitle><date>2008-05-01</date><risdate>2008</risdate><volume>277</volume><issue>5</issue><spage>411</spage><epage>414</epage><pages>411-414</pages><issn>0932-0067</issn><eissn>1432-0711</eissn><abstract>Objective
Borderline epithelial ovarian tumors have good prognosis without any adjuvant therapy. The advantage of aggressive surgical staging, especially retroperitoneal lymph node sampling is questionable in patients with borderline ovarian tumors. We designed this study to evaluate the necessity of retroperitoneal pelvic and para-aortic lymph node dissection in the treatment of borderline epithelial ovarian tumors.
Study design
From 1998 to 2007, 57 women who were diagnosed with borderline epithelial ovarian tumor in our hospital were prospectively accrued and evaluated; 27 of them (47.3%) had full surgical staging procedure including para-aortic and pelvic node dissection. Student’s
t
-test was used to compare follow-up times.
Results
Median follow-up time was 54.6 (12–96) months for all patients in the study. There was one recurrence of disease, which was in the complete staging group. Follow-up times of patients were not statistically different between lymph node evaluated and non-evaluated groups (
p
= 0.10). We did not find any metastasis in lymph nodes in 27 women who had complete surgical staging procedure.
Conclusion
Patients with borderline epithelial tumors who had full surgical staging procedure do not have survival advantage over those who had no lymph node evaluation and yet were patients with malignant ovarian tumors.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>17940784</pmid><doi>10.1007/s00404-007-0478-2</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0932-0067 |
| ispartof | Archives of gynecology and obstetrics, 2008-05, Vol.277 (5), p.411-414 |
| issn | 0932-0067 1432-0711 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70449572 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Adult Aged Biopsy Carcinoma - pathology Carcinoma - surgery Endocrinology Female Follow-Up Studies Gynecology Human Genetics Humans Lymph Node Excision Lymphatic system Medical prognosis Medicine Medicine & Public Health Middle Aged Needs Assessment Neoplasm Staging Obstetrics/Perinatology/Midwifery Original Article Ovarian cancer Ovarian Neoplasms - pathology Ovarian Neoplasms - surgery Prospective Studies Retroperitoneal Space Treatment Outcome Tumors |
| title | Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T04%3A28%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20it%20necessary%20to%20do%20retroperitoneal%20evaluation%20in%20borderline%20epithelial%20ovarian%20tumors?&rft.jtitle=Archives%20of%20gynecology%20and%20obstetrics&rft.au=Pirimoglu,%20Zehra%20Meltem&rft.date=2008-05-01&rft.volume=277&rft.issue=5&rft.spage=411&rft.epage=414&rft.pages=411-414&rft.issn=0932-0067&rft.eissn=1432-0711&rft_id=info:doi/10.1007/s00404-007-0478-2&rft_dat=%3Cproquest_cross%3E2261889403%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2261889403&rft_id=info:pmid/17940784&rfr_iscdi=true |